Last updated: 29 February 2024 at 6:06pm EST

Seth Lederman Net Worth




The estimated Net Worth of Seth Lederman is at least $1.29 Million dollars as of 29 June 2022. Seth Lederman owns over 20,000 units of Tonix Pharmaceuticals Corp stock worth over $3,635 and over the last 12 years he sold TNXP stock worth over $0. In addition, he makes $1,288,270 as Chairman of the Board, President, and Chief Executive Officer at Tonix Pharmaceuticals Corp.

Seth Lederman TNXP stock SEC Form 4 insiders trading

Seth has made over 35 trades of the Tonix Pharmaceuticals Corp stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of TNXP stock worth $34,200 on 29 June 2022.

The largest trade he's ever made was buying 100,000 units of Tonix Pharmaceuticals Corp stock on 25 March 2022 worth over $25,000. On average, Seth trades about 10,954 units every 62 days since 2013. As of 29 June 2022 he still owns at least 24,235 units of Tonix Pharmaceuticals Corp stock.

You can see the complete history of Seth Lederman stock trades at the bottom of the page.





Seth Lederman biography

Dr. Seth Lederman M.D. serves as Chairman of the Board, President, Chief Executive Officer of the Company. since October 7, 2011. He founded Tonix Pharmaceuticals, Inc., a wholly-owned subsidiary of the Company (“Tonix Sub”) in 2007 and has acted as its Chairman of the Board of Directors since its inception and as President since 2010. Dr. Lederman is an inventor on key patents and patent applications underlying our programs including: TNX-102 SL’s eutectic composition; Tonmya’s pharmacokinetic profile and related therapeutic properties, and Tonmya for posttraumatic stress disorder (PTSD). Dr. Lederman served as an Associate Professor at Columbia University, between 1996 and 2017. As an Assistant Professor at Columbia, Dr. Lederman discovered and characterized the CD40-ligand and invented therapeutic candidates to treat autoimmune diseases and transplant rejection. Dr. Lederman has been a Manager of L&L Technologies LLC, or L&L, since 1996. In addition, Dr. Lederman has been the Managing Member of Seth Lederman Co, LLC since 2007 and the Managing Member of Lederman & Co, LLC, or Lederman & Co, since 2002, both of which are biopharmaceutical consulting and investing companies. Dr. Lederman has also been the Managing Member of Targent Pharmaceuticals, LLC, or Targent, since 2000, and Managing Member of Plumbline LLC since 2002. Targent was a founder of Targent Pharmaceuticals Inc. on which Board of Directors Dr. Lederman served from inception in 2001 until the sale of its assets to Spectrum Pharmaceuticals Inc. Between 2007 and 2008, Dr. Lederman was Chairman of Validus Pharmaceuticals, Inc. and Fontus Pharmaceuticals, Inc. Dr. Lederman received his BA degree in Chemistry from Princeton University in 1979 and his MD from Columbia University in 1983.

What is the salary of Seth Lederman?

As the Chairman of the Board, President, and Chief Executive Officer of Tonix Pharmaceuticals Corp, the total compensation of Seth Lederman at Tonix Pharmaceuticals Corp is $1,288,270. There are no executives at Tonix Pharmaceuticals Corp getting paid more.



How old is Seth Lederman?

Seth Lederman is 62, he's been the Chairman of the Board, President, and Chief Executive Officer of Tonix Pharmaceuticals Corp since 2011. There are 7 older and 8 younger executives at Tonix Pharmaceuticals Corp. The oldest executive at Tonix Pharmaceuticals Holding Corp is Adeoye Olukotun, 75, who is the Independent Director.

What's Seth Lederman's mailing address?

Seth's mailing address filed with the SEC is 509 Madison Ave #306, New York, NY 10022, USA.

Insiders trading at Tonix Pharmaceuticals Corp

Over the last 12 years, insiders at Tonix Pharmaceuticals Corp have traded over $155,884 worth of Tonix Pharmaceuticals Corp stock and bought 1,820,071 units worth $3,399,062 . The most active insiders traders include Ernest Mario, Seth Lederman, and Bruce Daugherty. On average, Tonix Pharmaceuticals Corp executives and independent directors trade stock every 32 days with the average trade being worth of $2,734. The most recent stock trade was executed by Seth Lederman on 29 June 2022, trading 20,000 units of TNXP stock currently worth $34,200.



What does Tonix Pharmaceuticals Corp do?

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.



What does Tonix Pharmaceuticals Corp's logo look like?

Tonix Pharmaceuticals Holding Corp logo

Complete history of Seth Lederman stock trades at Tonix Pharmaceuticals Corp

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
29 Jun 2022 Seth Lederman
Chief Executive Officer
Buy 20,000 $1.71 $34,200
29 Jun 2022
24,235
25 Mar 2022 Seth Lederman
Chief Executive Officer
Buy 100,000 $0.25 $25,000
25 Mar 2022
112,177
28 Sep 2021 Seth Lederman
Chief Executive Officer
Buy 12,000 $0.61 $7,320
28 Sep 2021
12,177
24 Mar 2021 Seth Lederman
Chief Executive Officer
Buy 16,733 $1.32 $22,088
24 Mar 2021
135,000
30 Dec 2020 Seth Lederman
Chief Executive Officer
Buy 35,000 $0.68 $23,800
30 Dec 2020
118,267
13 Aug 2020 Seth Lederman
Chief Executive Officer
Buy 60,000 $0.91 $54,600
13 Aug 2020
83,267
3 Dec 2019 Seth Lederman
Chief Executive Officer
Buy 20,000 $1.16 $23,200
3 Dec 2019
23,267
29 Mar 2019 Seth Lederman
Chief Executive Officer
Buy 5,000 $2.49 $12,450
29 Mar 2019
32,670
26 Mar 2019 Seth Lederman
Chief Executive Officer
Buy 25,000 $2.38 $59,500
26 Mar 2019
27,670
29 Jun 2018 Seth Lederman
Chief Executive Officer
Buy 500 $4.64 $2,320
29 Jun 2018
17,666
28 Jun 2018 Seth Lederman
Chief Executive Officer
Buy 500 $4.58 $2,290
28 Jun 2018
17,166
27 Jun 2018 Seth Lederman
Chief Executive Officer
Buy 500 $4.55 $2,275
27 Jun 2018
16,666
12 Jun 2018 Seth Lederman
Chief Executive Officer
Buy 3,000 $4.37 $13,110
12 Jun 2018
20,463
25 May 2018 Seth Lederman
Chief Executive Officer
Buy 4,000 $3.17 $12,680
25 May 2018
26,700
26 Dec 2017 Seth Lederman
Chief Executive Officer
Buy 5,300 $3.61 $19,133
26 Dec 2017
22,700
16 Aug 2017 Seth Lederman
Chief Executive Officer
Buy 20,000 $3.00 $60,000
16 Aug 2017
50,000
30 Jun 2017 Seth Lederman
Chief Executive Officer
Buy 5,000 $4.33 $21,650
30 Jun 2017
30,000
26 Jun 2017 Seth Lederman
Chief Executive Officer
Buy 5,000 $4.40 $22,000
26 Jun 2017
25,000
19 Jun 2017 Seth Lederman
Chief Executive Officer
Buy 20,000 $4.22 $84,400
19 Jun 2017
20,000
21 Nov 2016 Seth Lederman
Chief Executive Officer
Buy 98,000 $0.43 $42,140
21 Nov 2016
133,000
31 Oct 2016 Seth Lederman
Chief Executive Officer
Buy 10,000 $4.00 $40,000
31 Oct 2016
90,815
22 Jun 2016 Seth Lederman
Chief Executive Officer
Buy 20,000 $2.08 $41,600
22 Jun 2016
20,000
22 Jun 2016 Seth Lederman
Chief Executive Officer
Buy 20,000 $2.08 $41,600
22 Jun 2016
20,000
21 Jun 2016 Seth Lederman
Chief Executive Officer
Buy 25,000 $2.00 $50,000
21 Jun 2016
31,000
21 Jun 2016 Seth Lederman
Chief Executive Officer
Buy 25,000 $2.00 $50,000
21 Jun 2016
31,000
23 Mar 2016 Seth Lederman
Chief Executive Officer
Buy 8,000 $2.44 $19,520
23 Mar 2016
80,815
25 Sep 2015 Seth Lederman
Chief Executive Officer
Buy 6,000 $6.50 $39,000
25 Sep 2015
71,074
17 Jul 2015 Seth Lederman
Chief Executive Officer
Buy 6,000 $7.50 $45,000
17 Jul 2015
6,000
16 Mar 2015 Seth Lederman
Chief Executive Officer
Buy 2,000 $7.02 $14,040
16 Mar 2015
65,074
12 Mar 2015 Seth Lederman
Chief Executive Officer
Buy 2,000 $7.24 $14,480
12 Mar 2015
63,074
10 Mar 2015 Seth Lederman
Chief Executive Officer
Buy 2,000 $6.95 $13,900
10 Mar 2015
61,074
6 Mar 2015 Seth Lederman
Chief Executive Officer
Buy 2,000 $6.48 $12,960
6 Mar 2015
59,074
4 Mar 2015 Seth Lederman
Chief Executive Officer
Buy 2,000 $6.27 $12,540
4 Mar 2015
57,074
9 Feb 2015 Seth Lederman
Chief Executive Officer
Buy 5,000 $5.85 $29,250
9 Feb 2015
55,074
20 May 2013 Seth Lederman
Chief Executive Officer
Buy 1,000 $7.30 $7,300
20 May 2013
38,309


Tonix Pharmaceuticals Corp executives and stock owners

Tonix Pharmaceuticals Corp executives and other stock owners filed with the SEC include: